Stay updated on Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a non-content software/version update for the ClinicalTrials.gov site.
    Difference
    0.0%
    Check dated 2026-04-25T06:14:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added Melanoma as a topic and MedlinePlus Genetics as related topics; updated the Revision tag to v3.5.2 from v3.5.0.
    Difference
    0.2%
    Check dated 2026-04-18T03:53:08.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Removed the condition 'Melanoma' and the related topic 'MedlinePlus Genetics' from the page. This reduces central disease context and the linked resources presented to users.
    Difference
    0.1%
    Check dated 2026-04-10T22:15:34.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics, and updated revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-20T06:53:36.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Removed Melanoma and the related topic MedlinePlus Genetics from the page's related topics.
    Difference
    0.1%
    Check dated 2026-03-13T01:23:39.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-05T19:45:35.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab Regimens in Melanoma Clinical Trial page.